top of page
Signing a Contract




An expanded universe of stakeholders–including payers, policy makers, physicians, and patients–all share in the responsibility for defining the clinical, economic, and societal value of today’s revolutionary new treatments. Accordingly, our team works with clients on reimbursement and market access strategy to provide a better understanding of the current and future landscape in order to better align, support, and demonstrate evidence of product value to ensure commercial adoption and excellence. 

Our Offerings

We offer a range of services to support reimbursement and market access strategy decisions, from payer segmentation analysis to coverage and access trends

Payer Segmentation Analysis 

Pre-Launch and Post-Launch Reimbursement Strategy 

Payer and Organized Provider Value Proposition Development and Testing 

Value Message Framework Construction 

Competitive Simulation Workshops 

Coverage and Access Trends

Case Study

A public biopharma company had a novel pre-commercial therapeutic to treat diseases of the eye and recognized that the construction of payer coverage policies would be a critical factor in determining access to their product.

Case Study:

Development of Strategic Payer Insights

Interested in learning more?

Are you a health tech founder?

bottom of page